BL
Insider
Brian Guan-Chyun Liu
DirectorBrian Guan-Chyun Liu (Director) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in CG Oncology, Inc. (CGON). Across 1 priced purchase filing, the average 21-session return was +8.0% from execution and +3.3% from disclosure (delay-adjusted; derived). The largest single filing was $24.8M of CGON (371,085 sh × $66.87, as filed), executed Jun 25.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
+8.0%
avg across 1 priced filings
Delay-adjustediThe same average, entered at disclosure dates
+3.3%
same 1 filings, from disclosure
Filings, ttm
1
1 buys · 0 sells
Median delay
4d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$24.8M
shares × price, as filed
Last traded
Jun 25
Filed Jun 29
Median ADV $76.8M across their filed names
Open performance→Volume by month
Buys $74.8M
Sells $0
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
CGON
CG Oncology, Inc.
CGON · 2 buys · 0 sells
2 filings
Recent filings
CGONPURCHASE
CG Oncology, Inc.
View filing →
$24.8M371,085 sh × $66.87
Exec Jun 25
Filed Jun 29 · 5:26 PM ET CGONPURCHASE CG Oncology, Inc. View filing → $50.0M
1,515,151 sh × $33.00
Exec Sep 11 2025
Filed Sep 15 2025 · 8:32 AM ET